Laboratory Monitoring of Pentasaccharide in a Dog Model of Hemodialysis
- 1 October 1999
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 96 (2) , 115-124
- https://doi.org/10.1016/s0049-3848(99)00094-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic PentasaccharideBlood, 1998
- EFFICACY OF PENTASACCHARIDE IN A DOG MODEL OF HEMODIALYSISThrombosis Research, 1997
- Biochemical and Pharmacological Properties of SANORG 32701Circulation Research, 1996
- Thrombopénie à l'héparine sous hémodialyse en réanimation : utilisation d'un héparinoïde de bas poids moléculaire, l'ORG 10 172 (Orgaran®)Annales Françaises dʼAnesthésie et de Réanimation, 1995
- A comparison between the use of recombinant hirudin and heparin during hemodialysisKidney International, 1995
- The Adequacy of Fragmin as a Single Bolus Dose with Reused DialyzersArtificial Organs, 1994
- Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysisKidney International, 1994
- Current trends in the development of anticoagulant and antithrombotic drugsMedical Clinics of North America, 1994
- Low Molecular Weight Heparin (CY-216) versus Unfractionated Heparin in Chronic HemodialysisNephron, 1992
- Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis modelThrombosis Research, 1986